Loss of SUV420H2 promotes EGFR inhibitor resistance in NSCLC through upregulation of MET via LINC01510
Published date:
03/18/2020
Excerpt:
The findings from this study identified an
epigenetic factor, SUV420H2 that when lost drives resistance of NSCLC to multiple EGFRi,
including erlotinib, gefitinib, afatinib, and osimertinib.